10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 151,036 | 150,843 | 166,030 | 149,002 | 172,908 |
| Cost of Goods | 38,539 | 44,665 | 52,985 | 48,695 | 47,824 |
| Gross Profit | 112,497 | 106,178 | 113,045 | 100,307 | 125,084 |
| Operating Expenses | 132,591 | 123,889 | 133,571 | 133,244 | 95,782 |
| Operating Income | -19,555 | -17,046 | -19,541 | -32,242 | 30,126 |
| Interest Expense | 0 | 0 | 0 | -3 | 3 |
| Other Income | 910 | 4,199 | 4,348 | 4,034 | 6,874 |
| Pre-tax Income | -18,645 | -12,847 | -15,193 | -28,205 | 36,997 |
| Income Tax | -714 | 623 | 1,059 | -733 | 2,459 |
| Net Income Continuous | -17,931 | -13,470 | -16,252 | -27,472 | 34,538 |
| Net Income | $-17,931 | $-13,470 | $-16,252 | $-27,472 | $34,538 |
| EPS Basic Total Ops | -0.14 | -0.10 | -0.13 | -0.22 | 0.28 |
| EPS Basic Continuous Ops | -0.14 | -0.11 | -0.13 | -0.22 | 0.28 |
| EPS Diluted Total Ops | -0.14 | -0.10 | -0.13 | -0.22 | 0.28 |
| EPS Diluted Continuous Ops | -0.14 | -0.11 | -0.13 | -0.22 | 0.28 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.10 | -0.13 | -0.22 | 0.28 |
| EBITDA(a) | $-5,922 | $-7,089 | $-8,255 | $-19,177 | $41,569 |